rs748509684

Variant summary

Our verdict is Likely benign. The variant received -3 ACMG points: 2P and 5B. PM2BP4_ModerateBP6_ModerateBP7

The NM_021098.3(CACNA1H):​c.2538C>A​(p.Ala846Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000274 in 1,460,742 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★). Synonymous variant affecting the same amino acid position (i.e. A846A) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000027 ( 0 hom. )

Consequence

CACNA1H
NM_021098.3 synonymous

Scores

2

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.00500

Publications

0 publications found
Variant links:
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
  • hyperaldosteronism, familial, type IV
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • childhood absence epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • epilepsy, childhood absence, susceptibility to, 6
    Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -3 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.41).
BP6
Variant 16-1205200-C-A is Benign according to our data. Variant chr16-1205200-C-A is described in ClinVar as Likely_benign. ClinVar VariationId is 1620842.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=-0.005 with no splicing effect.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1HNM_021098.3 linkc.2538C>A p.Ala846Ala synonymous_variant Exon 11 of 35 ENST00000348261.11 NP_066921.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1HENST00000348261.11 linkc.2538C>A p.Ala846Ala synonymous_variant Exon 11 of 35 1 NM_021098.3 ENSP00000334198.7
CACNA1HENST00000569107.6 linkc.2538C>A p.Ala846Ala synonymous_variant Exon 11 of 34 1 ENSP00000454990.2
CACNA1HENST00000711493.1 linkc.2538C>A p.Ala846Ala synonymous_variant Exon 11 of 34 ENSP00000518778.1
CACNA1HENST00000565831.7 linkc.2538C>A p.Ala846Ala synonymous_variant Exon 11 of 34 1 ENSP00000455840.1
CACNA1HENST00000711450.1 linkc.2538C>A p.Ala846Ala synonymous_variant Exon 11 of 35 ENSP00000518762.1
CACNA1HENST00000564231.6 linkc.2538C>A p.Ala846Ala synonymous_variant Exon 11 of 35 1 ENSP00000457555.2
CACNA1HENST00000638323.1 linkc.2499C>A p.Ala833Ala synonymous_variant Exon 11 of 35 5 ENSP00000492267.1
CACNA1HENST00000562079.6 linkc.2538C>A p.Ala846Ala synonymous_variant Exon 11 of 34 1 ENSP00000454581.2
CACNA1HENST00000711438.1 linkc.2499C>A p.Ala833Ala synonymous_variant Exon 11 of 34 ENSP00000518754.1
CACNA1HENST00000711482.1 linkc.2538C>A p.Ala846Ala synonymous_variant Exon 11 of 36 ENSP00000518771.1
CACNA1HENST00000711485.1 linkc.2538C>A p.Ala846Ala synonymous_variant Exon 11 of 35 ENSP00000518774.1
CACNA1HENST00000711455.1 linkc.2538C>A p.Ala846Ala synonymous_variant Exon 11 of 36 ENSP00000518768.1
CACNA1HENST00000711483.1 linkc.2538C>A p.Ala846Ala synonymous_variant Exon 11 of 35 ENSP00000518772.1
CACNA1HENST00000711456.1 linkc.2538C>A p.Ala846Ala synonymous_variant Exon 11 of 34 ENSP00000518769.1
CACNA1HENST00000621827.2 linkn.2538C>A non_coding_transcript_exon_variant Exon 11 of 37 6 ENSP00000518766.1
CACNA1HENST00000637236.3 linkn.2538C>A non_coding_transcript_exon_variant Exon 11 of 34 5 ENSP00000492650.2
CACNA1HENST00000639478.1 linkn.2538C>A non_coding_transcript_exon_variant Exon 11 of 35 5 ENSP00000491945.1
CACNA1HENST00000640028.1 linkn.*451C>A non_coding_transcript_exon_variant Exon 11 of 35 5 ENSP00000491488.1
CACNA1HENST00000711442.1 linkn.*1985C>A non_coding_transcript_exon_variant Exon 10 of 34 ENSP00000518758.1
CACNA1HENST00000711448.1 linkn.2538C>A non_coding_transcript_exon_variant Exon 11 of 36 ENSP00000518760.1
CACNA1HENST00000711449.1 linkn.2538C>A non_coding_transcript_exon_variant Exon 11 of 35 ENSP00000518761.1
CACNA1HENST00000711451.1 linkn.2538C>A non_coding_transcript_exon_variant Exon 11 of 36 ENSP00000518763.1
CACNA1HENST00000711452.1 linkn.2538C>A non_coding_transcript_exon_variant Exon 11 of 36 ENSP00000518764.1
CACNA1HENST00000711453.1 linkn.2538C>A non_coding_transcript_exon_variant Exon 11 of 36 ENSP00000518765.1
CACNA1HENST00000711484.1 linkn.2538C>A non_coding_transcript_exon_variant Exon 11 of 35 ENSP00000518773.1
CACNA1HENST00000711486.1 linkn.2538C>A non_coding_transcript_exon_variant Exon 11 of 37 ENSP00000518775.1
CACNA1HENST00000711487.1 linkn.2538C>A non_coding_transcript_exon_variant Exon 11 of 36 ENSP00000518776.1
CACNA1HENST00000711488.1 linkn.2538C>A non_coding_transcript_exon_variant Exon 11 of 35 ENSP00000518777.1
CACNA1HENST00000640028.1 linkn.*451C>A 3_prime_UTR_variant Exon 11 of 35 5 ENSP00000491488.1
CACNA1HENST00000711442.1 linkn.*1985C>A 3_prime_UTR_variant Exon 10 of 34 ENSP00000518758.1

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
AF:
0.00000274
AC:
4
AN:
1460742
Hom.:
0
Cov.:
32
AF XY:
0.00000138
AC XY:
1
AN XY:
726636
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33480
American (AMR)
AF:
0.00
AC:
0
AN:
44706
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26108
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86250
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52634
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5762
European-Non Finnish (NFE)
AF:
0.00000360
AC:
4
AN:
1111758
Other (OTH)
AF:
0.00
AC:
0
AN:
60344
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Dec 11, 2020
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.41
CADD
Benign
6.8
DANN
Benign
0.72
PhyloP100
-0.0050

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs748509684; hg19: chr16-1255200; API